21st ANNUAL CUTTING EDGE CONFERENCE (VIRTUAL)
Thursday, August 20th, 2020
8 a.m.- 4 p.m.
Organ transplantation remains a dynamic field of continued interest and excitement. The 2020 Cutting Edge in Transplantation Conference will focus on historical perspectives and new insights gained through technological advances, research, and novel interventions in organ transplant.
Healthcare professionals including physicians, nurses, pharmacists, care coordinators, social workers, and other allied healthcare providers.
Upon completion of this program, participants should be able to:
- Understand how three - and five -year lung transplant outcomes differ between OCS preserved organ(s) and standard preservation techniques
- Describe the unique management issues for the HCV negative recipient of an HCV positive donor organ
- Understand the unique circumstances that enabled Kidney Paired Donation breakthrough
- Relate the use of Pharmacogenomics to the clinical care of the transplant recipient
- Understand the challenges associated with the use of an LVAD in a patient with a single ventricle
- Indicate one clinically important difference between the PEth test and ETG test for alcohol use
- Identify one side effect of an oral antidiabetic agent in transplant recipients
- Describe how the new recommendations for psychosocial assessment in the heart transplant, and LVAD candidate is operationalized
- Discuss the risks for women having pregnancies after kidney donation
- Know the meanings of terminology used today
2020 Cutting Edge Conference – Agenda
8:00 a.m.-8:15 a.m. – Introduction
8:15 a.m.-8:30 a.m. - Real Patients, Real Stories #1
8:30 a.m.- 9:00 a.m. - Hep C Positive Donor to Hep C Negative Recipient - Thomas Leventhal, MD
9:00 a.m.-9:15 a.m. – Break
9:15 a.m. - 9:45 a.m. - Three-and Five-Year OCS Outcomes in Lung Transplant - Stephen Huddleston, MD, PhD
9:45 a.m.-10:15 a.m. – Kidney Paired Donation: How it started and Where It is Going - Robert Montgomery, MD, D. Phil
10:15 a.m.-10:45 a.m. – Break
10:45 a.m.-11:15 a.m. - Pharmacogenomics and Transplant - Pamala Jacobson, PharmD, FCCP
11:15 a.m.-11:30 a.m. - Real Patients, Real Stories #2
11:30 a.m.-12:00 p.m. - The Use of HeartMate III in a Single Ventricle Patient - Massimo Griselli, MD MS, FCRS
12:00 p.m.-1:00 p.m. - Lunch
1:00 p.m.- 1:30 p.m. - The Use of PEth testing vs. ETG Testing - Nicholas Lim, MB, BCH BAO
1:30 p.m.-2:00 p.m. - Use of Antidiabetic Medications in Transplant Patients - Tasma Harindhanavudhi, MD
2:00 p.m.-2:15 p.m. - Real Patients, Real Stories #3
2:15 p.m.-2:30 p.m. - Break
2:30 p.m.-3:00 p.m. - Psychosocial Evaluation of a Candidate for Transplant or Mechanical Circulatory Support - Angela Herr, LICSW and James Porter, PhD, LP, ABPP-CN
3:00 p.m.-3:30 p.m. - Pregnancy after Living Kidney Donation - Arthur Matas, MD
3:30 p.m.-4:00 p.m. - Cannabis, What's All the Fuss? - Christopher Martin, R.Ph.
American Board for Transplant Certification
The program is designed to meet the American Board for Transplant Certification for up to 5.0 Category 1 continuing education points for transplant certification for transplant coordinators and transplant-certified nurses.
Minnesota Board of Nursing
This program is designed to meet the Minnesota Board of Nursing continuing education requirements for up to 5.0 contact hours. Nurses are responsible for determining whether this activity meets the requirements for acceptable continuing education.
Minnesota Board of Pharmacy
University of Minnesota Medical Center has submitted an application to the Minnesota Board of Pharmacy for approval of this program for 5.0 hours of pharmacy continuing education. Pharmacists will need to apply to the Minnesota Board of Pharmacy if approval has not been granted by the date of conference.